home / stock / dtcff / dtcff quote
Last: | $0.6177 |
---|---|
Change Percent: | 4.97% |
Open: | $0.6177 |
Close: | $0.6177 |
High: | $0.6177 |
Low: | $0.6177 |
Volume: | 2,000 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6177 | $0.6177 | $0.6177 | $0.6177 | $0.6177 | 2,000 | 07-02-2024 |
$0.65 | $0.65 | $0.65 | $0.65 | $0.65 | 1,000 | 07-01-2024 |
$0.5723 | $0 | $0.5723 | $0 | $0 | 500 | 06-27-2024 |
$0.5723 | $0.5723 | $0.5723 | $0.5723 | $0.5723 | 1,061 | 06-26-2024 |
$0.5885 | $0.619 | $0.5885 | $0.619 | $0.5885 | 750 | 06-24-2024 |
$0.6252 | $0.6623 | $0.6252 | $0.6623 | $0.6252 | 3,000 | 06-21-2024 |
$0.8346 | $0.8346 | $0.8346 | $0.8346 | $0.8346 | 5,000 | 06-06-2024 |
$0.83 | $0.83 | $0.83 | $0.83 | $0.83 | 1,230 | 06-05-2024 |
$0.82 | $0.82 | $0.82 | $0.82 | $0.82 | 300 | 06-03-2024 |
$0.82 | $0.82 | $0.82 | $0.82 | $0.82 | 100 | 05-31-2024 |
$0.8118 | $0.8118 | $0.8118 | $0.8118 | $0.8118 | 1,045 | 05-30-2024 |
$0.85 | $0.85 | $0.85 | $0.85 | $0.85 | 200 | 05-28-2024 |
$0.9042 | $0 | $0.9042 | $0 | $0 | 3 | 05-22-2024 |
$0.9042 | $0.9042 | $0.9042 | $0.9042 | $0.9042 | 350 | 05-21-2024 |
$0.9779 | $0.9779 | $0.9779 | $0.9779 | $0.9779 | 750 | 05-10-2024 |
$1.03 | $0 | $1.03 | $0 | $0 | 10 | 05-09-2024 |
$1.03 | $1.0562 | $1.03 | $1.0562 | $1.03 | 1,000 | 05-07-2024 |
$1.04 | $1.04 | $1.04 | $1.04 | $1.04 | 1,000 | 05-06-2024 |
$0.85608 | $0.85608 | $0.85608 | $0.85608 | $0.85608 | 1,250 | 05-02-2024 |
$0.878 | $0.878 | $0.878 | $0.878 | $0.878 | 2,000 | 05-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Defence Therapeutics Inc Cl A Company Name:
DTCFF Stock Symbol:
OTCMKTS Market:
Defence Therapeutics Inc Cl A Website:
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce th...
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to share the interv...